NS

Ning Shen

FT Fulcrum Therapeutics: 2 patents #1 of 8Top 15%
SC Shanghai Haihe Pharmaceutical Co.: 1 patents #1 of 9Top 15%
📍 Beijing, MA: #31 of 124 inventorsTop 25%
Overall (2022): #67,721 of 548,613Top 15%
3
Patents 2022

Issued Patents 2022

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
11479770 Use of p38 inhibitors to reduce expression of DUX4 Angela Cacace, Luis Gustavo Alejandro Rojas Soto, Lorin A. Thompson, III, Owen Brendan Wallace, Lucienne V. Ronco +2 more 2022-10-25
11465984 Compound having ERK kinase inhibitory activity and use thereof Lei Li, Meiyu Geng, Ying-Huey Huang, Jian Ding, Qiong Zhang +3 more 2022-10-11
11291659 P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD Angela Cacace, Luis Gustavo Alejandro Rojas Soto, Lorin A. Thompson, III, Owen Brendan Wallace, Lucienne V. Ronco +2 more 2022-04-05